169 related articles for article (PubMed ID: 7819354)
21. [Primary and secondary prevention of Pneumocystis carinii pneumonia with pentamidine aerosol. Effectiveness, side effects and incidence of extrapulmonary Pneumocystis carinii manifestations].
Stoehr A; Plettenberg A; Albrecht H; Stellbrink HJ; Meigel W; Begemann F
Med Klin (Munich); 1994 Mar; 89(3):132-5. PubMed ID: 8196573
[TBL] [Abstract][Full Text] [Related]
22. Intravenous pentamidine for Pneumocystis carinii/jiroveci pneumonia prophylaxis in pediatric transplant patients.
Clark A; Hemmelgarn T; Danziger-Isakov L; Teusink A
Pediatr Transplant; 2015 May; 19(3):326-31. PubMed ID: 25712369
[TBL] [Abstract][Full Text] [Related]
23. Pneumocystis carinii pneumonia prophylaxis during pregnancy.
Connelly RT; Lourwood DL
Pharmacotherapy; 1994; 14(4):424-9. PubMed ID: 7937279
[TBL] [Abstract][Full Text] [Related]
24. Aerosolized pentamidine prophylaxis against AIDS-related Pneumocystis carinii pneumonia and its short- and long-term effects on pulmonary function in the Japanese.
Konishi M; Yoshimoto E; Takahashi K; Uno K; Kasahara K; Murakawa K; Maeda K; Mikasa K; Narita N
J Infect Chemother; 2003 Jun; 9(2):178-82. PubMed ID: 12825119
[TBL] [Abstract][Full Text] [Related]
25. The role of aerosol pentamidine prophylaxis.
Ong EL
Int J STD AIDS; 1993; 4(2):67-9. PubMed ID: 8476968
[TBL] [Abstract][Full Text] [Related]
26. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.
Ioannidis JP; Cappelleri JC; Skolnik PR; Lau J; Sacks HS
Arch Intern Med; 1996 Jan; 156(2):177-88. PubMed ID: 8546551
[TBL] [Abstract][Full Text] [Related]
27. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
Mallolas J; Zamora L; Gatell JM; Miró JM; Vernet E; Valls ME; Soriano E; SanMiguel JG
AIDS; 1993 Jan; 7(1):59-64. PubMed ID: 8442918
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
Martin MA; Cox PH; Beck K; Styer CM; Beall GN
Arch Intern Med; 1992 Mar; 152(3):523-8. PubMed ID: 1546914
[TBL] [Abstract][Full Text] [Related]
29. [Pneumocystis carinii infection during prophylaxis with nebulized pentamidine in a patient with AIDS].
de Jong MD; Lange JM; Smits NJ; Reiss P
Ned Tijdschr Geneeskd; 1991 Mar; 135(10):424-7. PubMed ID: 2020315
[TBL] [Abstract][Full Text] [Related]
30. Low incidence of Pneumocystis carinii pneumonia in HIV patients receiving 300 mg pentamidine aerosol every 2 weeks.
Kronawitter U; Bogner JR; Goebel FD
Clin Investig; 1992 Dec; 70(12):1089-91. PubMed ID: 1467635
[TBL] [Abstract][Full Text] [Related]
31. Aerosol pentamidine prophylaxis following Pneumocystis carinii pneumonia in AIDS patients: results of a blinded dose-comparison study using an ultrasonic nebulizer.
Murphy RL; Lavelle JP; Allan JD; Gordin FM; Dupliss R; Boswell SL; Waskin HA; Davies SF; Graziano FM; Saag MS
Am J Med; 1991 Apr; 90(4):418-26. PubMed ID: 2012082
[TBL] [Abstract][Full Text] [Related]
32. IV pentamidine prophylaxis for PCP.
AIDS Patient Care; 1995 Feb; 9(1):42. PubMed ID: 11361362
[No Abstract] [Full Text] [Related]
33. Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group.
Rizzardi GP; Lazzarin A; Musicco M; Frigerio D; Maillard M; Lucchini M; Moroni M
J Infect; 1996 Mar; 32(2):123-31. PubMed ID: 8708369
[TBL] [Abstract][Full Text] [Related]
34. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
[TBL] [Abstract][Full Text] [Related]
35. Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides.
Chan C; Montaner J; Lefebvre EA; Morey G; Dohn M; McIvor RA; Scott J; Marina R; Caldwell P
J Infect Dis; 1999 Aug; 180(2):369-76. PubMed ID: 10395851
[TBL] [Abstract][Full Text] [Related]
36. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection.
Gupta M; Stephenson K; Gauar S; Frenkel L
Pediatr Pulmonol Suppl; 1997; 16():199-200. PubMed ID: 9443273
[No Abstract] [Full Text] [Related]
37. A randomized comparison of once-monthly or twice-monthly high-dose aerosolized pentamidine prophylaxis.
Golden JA; Katz MH; Chernoff DN; Duncan SM; Conte JE
Chest; 1993 Sep; 104(3):743-50. PubMed ID: 8365284
[TBL] [Abstract][Full Text] [Related]
38. Once-a-month administration of intravenous pentamidine to patients infected with human immunodeficiency virus as prophylaxis for Pneumocystis carinii pneumonia.
Ena J; Amador C; Pasquau F; Carbonell C; Benito C; Gutiérrez F; Vilar A
Clin Infect Dis; 1994 Jun; 18(6):901-4. PubMed ID: 8086550
[TBL] [Abstract][Full Text] [Related]
39. Pneumocystis carinii infections in HIV-infected hemophiliacs during aerosolized pentamidine prophylaxis.
Ewig S; Rockstroh JK; Seitz HM; Marklein G; Christ F; Lüchters G; Brackmann HH; Lüderitz B
Respiration; 1993; 60(3):186-92. PubMed ID: 8210724
[TBL] [Abstract][Full Text] [Related]
40. Decreased efficacy of inhaled pentamidine in the prevention of Pneumocystis carinii pneumonia among HIV-infected patients with severe immunodeficiency.
Casale L; Gold H; Schechter C; Naficy A; Masci JR
Chest; 1993 Feb; 103(2):342-4. PubMed ID: 8094333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
